Related Experiment Video
Updated: May 10, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.8K
Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology
Nadeem R Abu-Rustum1, Susana M Campos2, Sudha Amarnath3
11Memorial Sloan Kettering Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|March 13, 2026
Summary
The NCCN Guidelines for Vaginal Cancer provide a framework for diagnosis, staging, and treatment of this rare cancer. Management strategies, especially systemic therapies, are often informed by cervical cancer research due to shared characteristics.
Area of Science:
- Gynecologic Oncology
- Clinical Practice Guidelines
- Oncology
Background:
- Vaginal cancer is a rare gynecologic malignancy.
- It shares biological and clinical similarities with cervical cancer.
- Management guidelines often extrapolate from cervical cancer data.
Purpose of the Study:
- To summarize the NCCN Clinical Practice Guidelines for Vaginal Cancer.
- To outline diagnostic workup, staging, and treatment strategies.
- To provide an overview of systemic therapy recommendations.
Main Methods:
- Review of the NCCN Clinical Practice Guidelines for Vaginal Cancer.
- Summarization of diagnostic, staging, and treatment principles.
- Inclusion of recommendations for early-stage, advanced, and recurrent disease.
Main Results:
- Key components of vaginal cancer management are detailed.
- Diagnostic evaluation, staging, and pathology considerations are outlined.
- Primary and relapse treatment recommendations, including systemic therapy, are provided.
Conclusions:
- The NCCN Guidelines offer a comprehensive approach to vaginal cancer management.
- Evidence from cervical cancer significantly influences systemic therapy recommendations.
- Guidelines cover the full spectrum of care from diagnosis to relapse management.
More Related Videos
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:19Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...